Manitol Viaflo Baxter

Mannitol, the active ingredient in Manitol Viaflo Baxter, is an osmotic diuretic presented as a solution for injection for intravenous use. It is employed to promote diuresis and to reduce elevated intracranial or intraocular pressure in appropriate clinical settings.

GNH USA supplies Manitol Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Manitol Viaflo Baxter is used in clinical situations where rapid osmotic diuresis or pressure reduction is required.

- Cerebral edema: helps lower intracranial pressure and limit brain swelling. - Acute glaucoma: reduces intraocular pressure to preserve vision. - Oliguric renal failure: increases urine output to support renal clearance.

Mannitol injection may be associated with several adverse reactions.

Common Side Effects: - Headache: mild to moderate discomfort often related to fluid shifts. - Nausea or vomiting: gastrointestinal upset following rapid infusion. - Thirst or dry mouth: due to osmotic draw of water. - Electrolyte imbalance: mild hyponatremia or hypokalemia. - Hypotension: transient drop in blood pressure during administration.

Serious or Rare Side Effects: - Acute renal failure: especially in patients with pre‑existing kidney disease. - Pulmonary edema: volume overload in susceptible individuals. - Severe electrolyte disturbances: marked hypernatremia or severe hyponatremia. - Anaphylactic reaction: rare but potentially life‑threatening hypersensitivity.

When considering Mannitol injection, clinicians should observe several safety measures.

- Renal function: assess baseline kidney status before initiating therapy. - Electrolytes: monitor serum sodium, potassium and osmolality during treatment. - Cardiac status: watch for signs of volume overload in patients with heart failure. - Intracranial dynamics: avoid rapid bolus in traumatic brain injury where abrupt shifts may worsen injury. - Pregnancy: use only if the anticipated benefit justifies potential risk to the fetus. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Mannitol may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Loop diuretics: additive diuretic effect can cause severe electrolyte loss. - ACE inhibitors or ARBs: increased risk of hypotension and renal impairment. - Insulin: osmotic shifts may potentiate hypoglycaemia. - Nephrotoxic agents: concurrent use may exacerbate renal injury.

Moderate Interactions (Monitor Closely): - Thyroid hormone preparations: altered serum concentrations may occur. - Antihypertensive drugs: dose adjustments may be needed due to additive blood‑pressure lowering effects.